Lv53
1028 积分 2024-04-22 加入
The PROTACtable genome
2个月前
已完结
Targeting spleen tyrosine kinase (SYK): structure, mechanisms and drug discovery
2个月前
已完结
Chemically engineered antibodies for autophagy-based receptor degradation
2个月前
已完结
R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation
2个月前
已完结
New insights into SYK targeting in solid tumors
2个月前
已完结
Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia
2个月前
已完结
Small-molecule displacement of a cryptic degron causes conditional protein degradation
2个月前
已完结
BTK-independent regulation of calcium signalling downstream of the B-cell receptor in malignant B-cells
2个月前
已完结
Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK)
2个月前
已完结
VHL-based PROTACs as potential therapeutic agents: Recent progress and perspectives
2个月前
已完结
皖公网安备34019202002308
